You are here

Article info

Article menu
Basic tumor immunology
Original research
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

Authors

  • Ana Marcu Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Leon Bichmann Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Leon Kuchenbecker Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Daniel Johannes Kowalewski Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Lena Katharina Freudenmann Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany PubMed articlesGoogle scholar articles
  • Linus Backert Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Lena Mühlenbruch Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany PubMed articlesGoogle scholar articles
  • András Szolek Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Maren Lübke Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Philipp Wagner Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Tobias Engler Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Sabine Matovina Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Jian Wang Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Mathias Hauri-Hohl Pediatric Stem Cell Transplantation, University Children’s Hospital Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Roland Martin Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Konstantina Kapolou Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Juliane Sarah Walz Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital of Tübingen, Tübingen, Germany Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany PubMed articlesGoogle scholar articles
  • Julia Velz Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Holger Moch Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Luca Regli Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Manuela Silginer Clinical Neuroscience Center and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Michael Weller Clinical Neuroscience Center and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Markus W. Löffler Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany Department of General, Visceral and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany Department of Clinical Pharmacology, University of Hospital Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Florian Erhard Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Bayern, Germany PubMed articlesGoogle scholar articles
  • Andreas Schlosser Rudolf Virchow Center - Center for Integrative and Translational Bioimaging, Julius-Maximilians-University Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Oliver Kohlbacher Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany Cluster of Excellence Machine Learning in the Sciences (EXC 2064), University of Tübingen, Tübingen, Germany Institute for Translational Bioinformatics, University Hospital Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Stefan Stevanović Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany PubMed articlesGoogle scholar articles
  • Hans-Georg Rammensee Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany PubMed articlesGoogle scholar articles
  • Marian Christoph Neidert Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland Department of Neurosurgery, Cantonal Hospital St.Gallen, St.Gallen, Switzerland Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles

Citation

Marcu A, Bichmann L, Kuchenbecker L, et al
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Journal for ImmunoTherapy of Cancer 2021;9:e002071. doi: 10.1136/jitc-2020-002071
Online issue publication 
May 06, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.